{
  "id": 16166165,
  "title": "Alnylam plans bigger study of RNA drug for Huntington’s disease",
  "url": "https://urgent.news/2026/10/23/alnylam-plans-bigger-study-of-rna-drug-for-huntingtons-disease",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-23T07:45:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/alnylam-plans-bigger-study-of-rna-drug-for-huntingtons-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "As with many of the most feared neurological conditions, Huntington’s disease has proven to be a minefield for drug developers. Promising biomarker data didn’t translate into clinical benefits in Roche’s recent study ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}